The NIH halted clinical trial of hydroxychloroquine
On Jun. 20, 2020, the National Institutes of Health (NIH) announced that a clinical trial to evaluate the…
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals began clinical trials
On Jun. 19, 2020, GSK announced that a scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19…
Dynavax announced first participants dosed in phase 1 clinical trial evaluating Clover Biopharma’s COVID-19 S-Trimer vaccine candidate with CpG 1018 adjuvant
On Jun. 19, 2020, Dynavax Technologies announced the first participants were dosed in the Phase 1 clinical trial…
COVID-19 Pandemic dramatically increased out-of-hospital cardiac arrest cases and deaths in New York City
On Jun. 19, 2020, the COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests…
The FDA announced participation in the COVID-19 Diagnostics Evidence Accelerator
On Jun. 18, 2020, the FDA announced participation in the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project…
Tonix Pharma and Southern Research announced expansion of COVID-19 vaccine collaboration
On Jun. 18, 2020, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include…
Oxford University and Bvlgari announced collaboration to fight COVID-19 and future pandemics
On Jun. 17, 2020, Bvlgari, the Italian luxury brand, announced plans to support research into COVID-19 and vaccine…
ViralClear opened enrollment with first patient dosing in phase II human trial of anti-viral MMPD oral solution for treatment of COVID-19
On Jun. 17, 2020, BioSig Technologies, and its subsidiary, ViralClear, announced that it had commenced patient enrollment with…
Innovation Pharma’s Brilacidin inhibited SARS-CoV-2 by 97 percent in a human lung cell line
On Jun. 17, 2020, Innovation Pharma reported receiving data from ongoing laboratory testing being conducted at a U.S….
Aclaris Therapeutics supported investigator-initiated clinical trial of ATI-450 for cytokine release syndrome in hospitalized COVID-19 patients
On Jun. 17, 2020, Aclaris Therapeutics announced that the FDA had allowed an investigational new drug application to…
Biotechnology | COVID-19 | Therapeutics | WHO
WHO announced preliminary results about dexamethasone use in treating critically ill COVID-19 patients
On Jun. 16, 2020, the World Health Organization (WHO) announced that initial clinical trial results from the United…
The FDA revoked Emergency Use Authorization for Chembio antibody test
On Jun. 16, 2020, the FDA revoked the emergency use authorization (EUA) of the Chembio Diagnostic System DPP…
All of Us Research Program launched COVID-19 research initiatives
On Jun. 16, 2020, the All of Us Research Program, part of the National Institutes of Health, announced…
Low-cost dexamethasone reduced death by up to one third in hospitalised patients with severe respiratory complications of COVID-19
On Jun. 16, 2020, the University of Oxford reported that overall dexamethasone reduced the 28-day mortality rate by…
San Diego’s scientific and medical institutes collaborated on large-scale research program to study spread of COVID-19
On Jun. 16, 2020, a consortium that includes many of San Diego’s top medical and scientific research institutes…
NanoString announced new products to advance COVID-19 disease research
On Jun. 16, 2020, NanoString Technologies announced the availability of new solutions to study the immune response in…
The FDA warned of newly discovered potential drug interaction that may reduce effectiveness of COVID-19 treatment
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) warned health care providers about a newly…
The FDA revoked Emergency Use Authorization for chloroquine and hydroxychloroquine
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that…
NIH launched analytics platform to harness nationwide COVID-19 patient data to speed treatments
On Jun. 15, 2020, the NIH announced it had launched a centralized, secure enclave to store and study…
Super-potent human antibodies protect against COVID-19 in animal tests
On Jun. 15, 2020, a team led by Scripps Research discovered antibodies in the blood of recovered COVID-19…
Mayo Clinic Study of Humanigen’s lenzilumab showed rapid recovery and discharged in severe and critical COVID-19 patients
On Jun. 15, 2020, Humanigen announced data on the first clinical use of lenzilumab in 12 COVID-19 patients….
Lilly begans phase 3 clinical trial with baricitinib for hospitalized COVID-19 patients
On Jun. 15, 2020, Eli Lilly announced that the first patient has been enrolled in a Phase 3…
Catalent announced agreement with AstraZeneca to manufacture COVID-19 vaccine candidate
On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…
Immunic announced first patients dosed in its phase 2, CALVID-1 clinical trial of IMU-838 in COVID-19
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
Cleveland Clinic researchers developed first model to predict likelihood of testing positive for COVID-19 and outcomes from the disease
On Jun. 15, 2020, Cleveland Clinic researchers announced they had developed the worldﾒs first risk prediction model for…
McKesson to distribute COVID-19 vaccines in support of Operation Warp Speed
On Jun. 14, 2020, McKesson announced that it had expanded its existing partnership with the Centers for Disease…
AstraZeneca to supply Europe with up to 400 million doses of Oxford Universityﾒs vaccine at no profit
On Jun. 13, 2020, AstraZeneca announced an agreement with Europeﾒs Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France,…
A cluster of COVID-19 in Beijing, People’s Republic of China was reported
On Jun. 13, 2020, officials from the WHO National Health Commission and Beijing Health Commission announced preliminary investigations…
Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for Remdesivir
On Jun. 13, 2020, Dr. Reddy’s Laboratories announced that it had entered into a non-exclusive Licensing Agreement with…
Sinovac announced positive preliminary results of phase I/II clinical trials for inactivated vaccine candidate against COVID-19
On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Companyﾒs…